In this study, we aimed to comprehensively characterize the immune microenvironment of gliomas based on IDH status, using RNA sequencing (RNA-Seq) and tumor-infiltrating lymphocyte (TIL) cultures. The gene discussed is IDH2; the disease is central nervous system cancer.